December 21, 2014 12:36 PM ET

Capital Markets

Company Overview of ChrysCapital

Company Overview

ChrysCapital is a private equity and venture capital firm specializing in management buy-outs or buy-ins, co-investments, public equity, PIPEs, growth capital in private and listed companies, and special situations including carve outs, joint ventures. The firm focuses on the business services; information technology; consumer goods and services; financial services; real estate; healthcare with a focus on pharmaceuticals, medical diagnostics and devices; infrastructure, power, and manufacturing sectors. It makes investments in companies based in or focusing on India and United States. The firm invests between $10 million and $300 million in companies with revenues ranging between $50 million...

Suite 504

St. James Court

Port Louis,  

Mauritius

Founded in 1999

Phone:

230 211 5410

Fax:

230 208 6413

Key Executives for ChrysCapital

Group Manager
Managing Director and Chief Financial Officer
Managing Director
Managing Director
Age: 37
Managing Director and Managing Partner
Age: 56
Compensation as of Fiscal Year 2014.

ChrysCapital Key Developments

Carlyle Reportedly Set To Acquire Destimoney From NSR

The Carlyle Group LP (NasdaqGS:CG) has come up as a frontrunner in race to acquire Destimoney Enterprises Private Limited from New Silk Route (NSR). According to the sources, the potential transaction is valued at INR 12 billion. The news report mentioned that formal announcement is due in the coming weeks. An official added, “Carlyle will most certainly buyout NSR from the housing finance JV. Last moment discussions are still on for the residual businesses like broking, distribution and I banking, which are much smaller in scale and size.” The news report mentioned that NSR and Carlyle's spokespersons declined to comment on the matter. Since 2013, NSR has been trying to monetize Destimoney investment and has had discussions with firms like General Atlantic LLC, Actis Capital, LLP, ChrysCapital and GIC Pte. Ltd. However, talks with most fell through.

ChrysCapital Presents at AVCJ Private Equity & Venture Forum - India 2014, Dec-03-2014 10:30 AM

ChrysCapital Presents at AVCJ Private Equity & Venture Forum - India 2014, Dec-03-2014 10:30 AM. Venue: Taj Lands End, Band Stand, Bandra (West), Mumbai 400 050, Maharashtra, India. Speakers: Sanjay Kukreja, Managing Director.

Warburg Pincus May Buy ChrysCap's Stake In Mankind Pharma

Warburg Pincus LLC is planning to acquire the 11% stake held by ChrysCapital in Mankind Pharma Limited for about $250 million, apart from making a primary infusion. If the deal goes through, ChrysCap would make a 9x returns on its seven year old investment.

Similar Private Companies By Industry

Company Name Region
Deutsche Securities Mauritius Limited Middle East/Africa
Citigroup Global Markets Mauritius Private Limited Middle East/Africa
L Capital Asia Advisors PLC Middle East/Africa
MEI Euro Finance Limited Middle East/Africa
Roseburg Inc Middle East/Africa

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
November 20, 2014
ING Vysya Bank Limited
Merger/Acquisition
September 2, 2014
Intas Pharmaceuticals Ltd.
Private Placement
April 15, 2014
Au FINANCIERS (INDIA) LIMITED
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ChrysCapital, please visit www.chryscapital.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.